With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.

News
Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a common pain reliever is linked to autism.

News